KUALA LUMPUR: A patient advocacy group has urged the government to encourage more companies to bring in the generic version of a medicine that treats advanced prostate cancer.
Although there is now one generic medicine, the therapy is still not affordable for the poor as well as middle-income Malaysians, says Together Against Cancer Malaysia chairman Wong Kuan Sing.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
